Covid-19: Vaccines and Medical Equipment Debate

Full Debate: Read Full Debate
Department: Department of Health and Social Care

Covid-19: Vaccines and Medical Equipment

Baroness Goudie Excerpts
Wednesday 25th November 2020

(4 years ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Asked by
Baroness Goudie Portrait Baroness Goudie
- Hansard - -

To ask Her Majesty’s Government what steps they are taking to ensure equitable access (1) to vaccines, and (2) to medical equipment, to address the Covid-19 pandemic.

Lord Bethell Portrait The Parliamentary Under-Secretary of State, Department of Health and Social Care (Lord Bethell) (Con)
- Hansard - - - Excerpts

My Lords, the UK is at the forefront of efforts to drive global collaboration on the development of new vaccines and has committed to procuring a Covid-19 vaccine for the UK, the Crown dependencies and the overseas territories. We are collaborating with international partners on vaccine development, manufacturing scale-up and future distribution. The NHS has allocated and assigned more than 28,000 items of critical care equipment across the UK and Crown dependencies and the remainder is available for allocation across England according to NHS regions, based on future need.

Baroness Goudie Portrait Baroness Goudie (Lab) [V]
- Hansard - -

My Lords, equitable access to vaccines has a number of dimensions and all must be secured across the world and in the UK. The Covid-19 pandemic respects no lines: if we neglect the developing world, we neglect ourselves. A lack of global access will hamper global health and development. Inequitable access would impede the unity of the United Kingdom.

Lord Bethell Portrait Lord Bethell (Con)
- Hansard - - - Excerpts

The UK has pledged more than £1 billion in aid to counter health, humanitarian and economic risks, including £829 million on the development and delivery of vaccines. I thank all those involved in the COVAX Facility, a multinational mechanism administered by Gavi which pools funding. The COVAX scheme is an emphatically impactful scheme. Britain has taken a leadership role in it, and I thank all those involved in its development.